Skip to main content
OpenTrials
Active, Not Recruiting

NCT Number: NCT07037225

Study of Cardiac Power Index During Supine, Lateral, and Between Left and Right Positions During Two- and One-Lung Ventilation (OLV): Comparison of Hemodynamic Changes After Lung Recruitment Maneuver and Fluid Challenge Among Responders and Non-Responders (SVI, MAP, CPI Changes).

The aim of this trial is to study the changes of the Cardiac Power Index (CPI) during supine and lateral decubitus position in two and one lung ventilation respectively. Moreover, CPI variations will be compared among patients in left versus patients in right lateral decubitus position.

A secondary goal is to compare the changes in hemodynamic parameters after a lung recruitment maneuver during one lung ventilation and a fluid challenge test among patients that respond (responders) or do not respond to fluids (non-responders) according to changes of Stroke Volume Index (SVI) and Mean Arterial Pressure (MAP).

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Attikon Hospital

Athens, Chaidari, 12462, Greece

About this study

This study investigates changes in Cardiac Power Index (CPI) in the same patients across different body positions (supine and lateral) during both two-lung ventilation (2LV) and one-lung ventilation (OLV). The primary aim is to assess how these positional and ventilation changes influence CPI values, a dynamic hemodynamic marker of cardiac function. A secondary objective is to evaluate the hemodynamic response to a recruitment maneuver and a fluid challenge, using stroke volume (SV) and mean arterial pressure (MAP) as indicators.

All measurements are performed with the chest closed, prior to surgical incision. Patients will be placed under general anesthesia with thoracic epidural support, and continuous hemodynamic monitoring will be established via a radial artery catheter connected to a HemoSphere monitor (Edwards Lifesciences). Key parameters monitored include CPI, cardiac index (CI), heart rate (HR), stroke volume index (SVI), and MAP.

Hemodynamic data will be collected at various predefined timepoints:

  • Baseline in the supine position under 2LV
  • Lateral position under OLV
  • Before and after a recruitment maneuver
  • Before and after a standardized fluid challenge

The recruitment maneuver consists of continuous positive airway pressure at 30 cmH₂O for 30 seconds. The fluid challenge involves administering 250 mL of isotonic saline over 10 minutes. Hemodynamic responses will be used to classify patients as fluid responders or non-responders based on ≥10% changes in SV and/or MAP.

Data analysis will focus on comparing CPI trends across positions and ventilation modes, as well as evaluating the utility of CPI in predicting fluid responsiveness. Hemodynamic parameters will be collected digitally and analyzed for intraoperative trends.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18
  • Physical status ASA I-III (per the American Society of Anesthesiologists)
  • Fluent in Greek or English
  • Scheduled for thoracic surgery using a double-lumen endotracheal tube

Exclusion criteria

  • Known arrhythmia
  • Severe valvular disease
  • Severe right or left ventricular dysfunction
  • Morbid obesity (BMI ≥ 40 kg/m²)
  • Inability to perform spirometry and/or echocardiography
  • Patient refusal to participate

Treatment and study plan

Fluid challenge during one-lung ventilation (OLV) in the lateral decubitus position

Other

During OLV, a lung recruitment maneuver will be performed, followed by measurements of CPI, CI, SVI, and MAP. A fluid challenge using 250 mL of normal saline (0.9% NaCl) will be administered. Hemodynamic parameters will be recorded at 2 and 5 minutes post-infusion. Patients will be classified as responders (SVI and MAP increase ≥10%) or non-responders. Changes in CPI will also be recorded accordingly.

Hemodynamic Monitoring

Device

Invasive hemodynamic monitoring will be performed using the HemoSphere device (Edwards Lifesciences).

Primary outcomes

  1. Change in Cardiac Power Index (CPI) Across Body Positions

    Time frame: up to 100 weeks

    Cardiac Power Index (CPI) will be measured in left, right and su pine positions to evaluate hemodynamic changes. CPI is calculated as (MAP × CO)/451 and indexed to body surface area.

    Unit of Measure: Watts/m²

Secondary outcomes

  1. Change in Stroke Volume Index (SVI) in Response to Fluid Challenge

    Time frame: up to 100 weeks

    SVI will be assessed after a fluid challenge during one-lung ventilation to evaluate responsiveness to fluid administration.

    Unit of Measure: mL/m²

  2. Change in Mean Arterial Pressure (MAP) in Response to Fluid Challenge

    Time frame: up to 100 weeks

    MAP will be measured in response to fluid challenge during one-lung ventilation.

    Unit of Measure: mmHg

  3. Change in Cardiac Power Index (CPI) in Response to Fluid Challenge

    Time frame: up to 100 weeks

    CPI will be monitored alongside SVI and MAP following fluid administration during one-lung ventilation to detect analogous hemodynamic changes.

    Unit of Measure: Watts/m²

Sponsors and collaborators

Lead sponsor

Maria Fountoulaki

Other

Registry information

Official study title

Hemodynamic Changes in Left and Right Lateral Position During One Lung Ventilation

Important dates

Study start
2025
Primary completion
2026
Study completion
2027
First posted
Jun 25, 2025
Registry last updated
Jun 25, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.